KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)

Q: What does CUSIP 483497103 represent in this 13F holders report?

CUSIP 483497103 is the security identifier for KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in Q3 2023?

101 institutional investors reported KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share for Q3 2023. Use the holders table for investor-level position and value details.

CUSIP: 483497103

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 51,679,622
Total 13F shares: 36,263,336
Share change: +1,818,240
Total reported value: $349,220,877
Put/Call ratio: 38%
Price per share: $9.63
Number of holders: 101
Value change: +$17,912,528
Number of buys: 50
Number of sells: 35

Quarterly Holders Quick Answers

What is CUSIP 483497103?
CUSIP 483497103 identifies KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2023
Previous quarter: Q2 2023

Recent filing periods for CUSIP 483497103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
TCG Crossover Management, LLC	13F	Company	6.6%	3,395,495	$30,559,455	—	30 Jun 2023	13F
Frazier Life Sciences Management, L.P.	13F	Company	6.3%	3,238,859	$29,149,731	—	30 Jun 2023	13F
VR Adviser, LLC	13F	Company	5.6%	2,916,667	$26,250,003	—	30 Jun 2023	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	5.1%	2,651,393	$23,862,537	—	30 Jun 2023	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	3.9%	2,034,506	$18,310,554	—	30 Jun 2023	13F
Boxer Capital, LLC	13F	Company	3.2%	1,650,000	$14,850,000	—	30 Jun 2023	13F
BlackRock Finance, Inc.	13F	Company	3.1%	1,599,738	$14,397,642	—	30 Jun 2023	13F
VANGUARD GROUP INC	13F	Company	3.1%	1,580,681	$14,226,129	—	30 Jun 2023	13F
Saturn V Capital Management LP	13F	Company	2.7%	1,412,336	$12,711,024	—	30 Jun 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	2.1%	1,104,339	$9,939,051	—	30 Jun 2023	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	2%	1,035,935	$9,323,415	—	30 Jun 2023	13F
Jefferies Financial Group Inc.	13F	Company	2%	1,030,000	$9,270,000	—	30 Jun 2023	13F
Vivo Capital, LLC	13F	Company	1.7%	856,008	$7,704,072	—	30 Jun 2023	13F
CITADEL ADVISORS LLC	13F	Company	1.6%	846,606	$7,619,454	—	30 Jun 2023	13F
MPM BioImpact LLC	13F	Company	1.5%	761,538	$6,853,842	—	30 Jun 2023	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	1.4%	720,508	$6,484,572	—	30 Jun 2023	13F
Opaleye Management Inc.	13F	Company	1.4%	720,000	$6,480,000	—	30 Jun 2023	13F
DAFNA Capital Management LLC	13F	Company	1.2%	611,032	$5,499,288	—	30 Jun 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.93%	480,425	$4,323,825	—	30 Jun 2023	13F
STATE STREET CORP	13F	Company	0.86%	446,175	$4,015,575	—	30 Jun 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.81%	420,536	$3,784,862	—	30 Jun 2023	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.76%	392,504	$3,532,536	—	30 Jun 2023	13F
Commodore Capital LP	13F	Company	0.6%	312,553	$2,812,977	—	30 Jun 2023	13F
CITIGROUP INC	13F	Company	0.58%	299,808	$2,698,272	—	30 Jun 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.57%	293,311	$2,639,799	—	30 Jun 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.56%	290,275	$2,612,475	—	30 Jun 2023	13F
NORTHERN TRUST CORP	13F	Company	0.51%	261,616	$2,354,544	—	30 Jun 2023	13F
Nan Fung Group Holdings Ltd	13F	Company	0.4%	204,720	$1,842,480	—	30 Jun 2023	13F
MORGAN STANLEY	13F	Company	0.39%	202,623	$1,823,607	—	30 Jun 2023	13F
Affinity Asset Advisors, LLC	13F	Company	0.34%	178,292	$1,604,628	—	30 Jun 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.28%	142,928	$1,286,000	—	30 Jun 2023	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	0.27%	140,200	$1,261,800	—	30 Jun 2023	13F
Ikarian Capital, LLC	13F	Company	0.27%	140,000	$1,260,000	—	30 Jun 2023	13F
AlphaCentric Advisors LLC	13F	Company	0.26%	135,000	$1,215,000	—	30 Jun 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.26%	133,122	$1,198,098	—	30 Jun 2023	13F
SG Americas Securities, LLC	13F	Company	0.23%	121,353	$1,092,000	—	30 Jun 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.23%	116,862	$1,051,758	—	30 Jun 2023	13F
Woodline Partners LP	13F	Company	0.21%	108,358	$975,222	—	30 Jun 2023	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.21%	107,975	$971,775	—	30 Jun 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.19%	99,162	$892,458	—	30 Jun 2023	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.17%	88,600	$797,400	—	30 Jun 2023	13F
Bank of New York Mellon Corp	13F	Company	0.16%	82,801	$745,209	—	30 Jun 2023	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.14%	72,540	$652,860	—	30 Jun 2023	13F
FMR LLC	13F	Company	0.14%	70,865	$637,785	—	30 Jun 2023	13F
HighVista Strategies LLC	13F	Company	0.13%	69,567	$626,103	—	30 Jun 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.13%	65,154	$586,386	—	30 Jun 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.12%	61,783	$556,047	—	30 Jun 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.12%	59,971	$539,739	—	30 Jun 2023	13F
CIBC WORLD MARKETS CORP	13F	Company	0.1%	50,000	$450,000	—	30 Jun 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.08%	41,731	$375,579	—	30 Jun 2023	13F

Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q3 2023

As of 30 Sep 2023, KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by 101 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,263,336 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, TCG Crossover Management, LLC, Frazier Life Sciences Management, L.P., VR Adviser, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, Saturn V Capital Management LP, VANGUARD GROUP INC, Boxer Capital, LLC, BlackRock Inc., and ADAGE CAPITAL PARTNERS GP, L.L.C.. This page lists 101 institutional shareholders reporting positions in this security for the Q3 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

101

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 Value $	Q3 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.